Philips receives FDA premarket approval for its HeartStart OnSite and HeartStart Home defibrillators
Amsterdam, the Netherlands –Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced that the Center for Devices and Radiological Health (CDRH) of the Food and Drug ...
Amsterdam, the Netherlands -Royal Philips(NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced shipment of its two-millionth AED (Automated External Defibrillator), which was ...
Philips is parting ways with its worldwide emergency care business, including its catalog of automated external defibrillators and other hardware used inside and outside the hospital, through a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback